Soheil Meshinchi

Active 1987–2025

119
Papers
18,819
Citations
64
h-index
109
i10-index

Citations

Citations per year for Soheil Meshinchi1943: 2 citations1987: 3 citations1988: 11 citations1989: 12 citations1990: 14 citations1991: 8 citations1992: 24 citations1993: 18 citations1994: 14 citations1995: 9 citations1996: 4 citations1997: 13 citations1998: 8 citations1999: 9 citations2000: 10 citations2001: 22 citations2002: 48 citations2003: 37 citations2004: 27 citations2005: 44 citations2006: 30 citations2007: 51 citations2008: 58 citations2009: 34 citations2010: 92 citations2011: 89 citations2012: 149 citations2013: 98 citations2014: 67 citations2015: 106 citations2016: 98 citations2017: 89 citations2018: 88 citations2019: 504 citations2020: 445 citations2021: 592 citations2022: 529 citations2023: 618 citations2024: 951 citations2025: 487 citations2026: 6 citations1944–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,093 citing papers, 30% of this breakdownChina: 533 citing papers, 7.6% of this breakdownGermany: 499 citing papers, 7.2% of this breakdownUnited Kingdom: 419 citing papers, 6% of this breakdownItaly: 382 citing papers, 5.5% of this breakdownFrance: 302 citing papers, 4.3% of this breakdownNetherlands: 271 citing papers, 3.9% of this breakdownCanada: 242 citing papers, 3.5% of this breakdownSpain: 188 citing papers, 2.7% of this breakdownJapan: 188 citing papers, 2.7% of this breakdownAustralia: 181 citing papers, 2.6% of this breakdownSweden: 155 citing papers, 2.2% of this breakdown
0%30%Other 21.8%

Fields

  • Medicine68.4%
  • Biochemistry, Genetics and Molecular Biology26.1%
  • Immunology and Microbiology3.5%
  • Neuroscience0.7%
  • Computer Science0.6%
  • Materials Science0.1%
  • Other0.6%

Topics

  • Acute Myeloid Leukemia Research16.9%
  • Acute Lymphoblastic Leukemia research6.3%
  • Chronic Myeloid Leukemia Treatments4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4%
  • Cancer Genomics and Diagnostics3.7%
  • Hematopoietic Stem Cell Transplantation2.5%
  • Other62.6%

Coauthors

All papers

Open in search
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joop H. Jansen, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Christian P. Kratz, Xiaoqiu Li, Megan S. Lim, Keith R. Loeb, Sanam Loghavi, Andrea N. Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P. Patel, Nikhil Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William A. Sewell, Reiner Siebert, Prashant Tembhare, Jeffrey Tyner, Srđan Verstovšek, Wei Wang, Brent L. Wood, Wenbin Xiao, Cecilia C.S. Yeung, Andreas Hochhaus - Leukemia 2022 cited by 3,904

  2. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2017 cited by 875

  3. Pan-cancer genome and transcriptome analyses of 1, 699 paediatric leukaemias and solid tumours

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen P. Hunger, Daniela S. Gerhard, Jinghui Zhang - Nature, Nat. 2018 cited by 961

  4. The genetic basis and cell of origin of mixed phenotype acute leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brent L. Wood, Nyla A. Heerema, Andrew Carrol, Yung‐Li Yang, Malcolm A. Smith, Tanja M. Davidsen, Leandro C. Hermida, Patee Gesuwan, Marco A. Marra, Yussanne Ma, Andrew J. Mungall, Richard A. Moore, Steven J.M. Jones, Marcus B. Valentine, Laura J. Janke, Jeffrey E. Rubnitz, Ching‐Hon Pui, Liang Ding, Yu Liu, Jinghui Zhang, Kim E. Nichols, James R. Downing, Xueyuan Cao, Lei Shi, Stanley Pounds, Scott Newman, Deqing Pei, Jaime M. Guidry Auvil, Daniela S. Gerhard, Stephen P. Hunger, Hiroto Inaba, Charles G. Mullighan - Nature 2018 cited by 374

  5. St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liqing Tian, Shaohua Lei, S. M. Ashiqul Islam, Christopher Meyer, Naina Thangaraj, Pamella Tater, Vijay Kandali, Singer Ma, Anh‐Tuan Nguyen, Omar Serang, Irina McGuire, Nedra Robison, Darrell Gentry, Xing Tang, Lance E. Palmer, Gang Wu, Ed Suh, Leigh Tanner, James McMurry, Matthew Lear, Alberto S. Pappo, Zhaoming Wang, Carmen L. Wilson, Yong Cheng, Soheil Meshinchi, Ludmil B. Alexandrov, Mitchell J. Weiss, Gregory T. Armstrong, Leslie L. Robison, Yutaka Yasui, Kim E. Nichols, David W. Ellison, Chaitanya Bangur, Charles G. Mullighan, Suzanne J. Baker, Michael A. Dyer, Geralyn M. Miller, Scott Newman, Michael Rusch, Richard Daly, Keith L. Perry, James R. Downing, Jinghui Zhang - Cancer Discovery 2021 cited by 261

  6. Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 472

  7. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A -Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 112

  8. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Eidenschink Brodersen, Michael R. Loken, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Timothy J. Triche, Bianca F. Goemans, Soheil Meshinchi - Haematologica 2023 cited by 71

  9. A longitudinal single-cell atlas of treatment response in pediatric AML

    Authors: , , , , , , , , , , , , , , - Cancer Cell 2023 cited by 69

  10. The genomic basis of childhood T-lineage acute lymphoblastic leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kimberly P. Dunsmore, Hiroto Inaba, William L. Carroll, Nilsa C. Ramirez, Aaron H. Phillips, Richard W. Kriwacki, Jun J. Yang, Tiffaney L. Vincent, Yaqi Zhao, Pankaj S. Ghate, Jian Wang, Colleen Reilly, Xin Zhou, Mathijs A. Sanders, Junko Takita, Motohiro Kato, Nao Takasugi, Bill H. Chang, Richard D. Press, Mignon L. Loh, Evadnie Rampersaud, Elizabeth A. Raetz, Stephen P. Hunger, Kai Tan, Ti‐Cheng Chang, Gang Wu, Stanley Pounds, Charles G. Mullighan, David T. Teachey - Nature 2024 cited by 137

  11. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2012 cited by 575

  12. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , - Leukemia 2019 cited by 131

  13. Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 101

  14. Automated CUT&Tag profiling of chromatin heterogeneity in mixed-lineage leukemia

    Authors: , , , , , , , - Nature Genetics 2021 cited by 99

  15. CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

    Authors: , , , , , , , , , , , , , , , , , - Blood 2021 cited by 120

  16. Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia

    Authors: , , , , , , , , - Pharmaceutics 2021 cited by 61

  17. Characteristics and prognostic impact ofIDHmutations in AML: a COG, SWOG, and ECOG analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2023 cited by 58

  18. Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

    Authors: , , , - Journal of Clinical Oncology 2011 cited by 837

  19. CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 111

  20. Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Miller, Jason R. Myers, Evadnie Rampersaud, Delaram Rahbarinia, Michael Rusch, Gang Wu, Hiroto Inaba, Yi‐Cheng Wang, Todd A. Alonzo, James R. Downing, Charles G. Mullighan, Stanley Pounds, M. Madan Babu, Jinghui Zhang, Jeffrey E. Rubnitz, Soheil Meshinchi, Xiaotu Ma, Jeffery M. Klco - Blood Cancer Discovery 2022 cited by 96

  21. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2010 cited by 581

  22. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

    Authors: , , , , , , , , , , - Blood 2012 cited by 293

  23. Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group

    Authors: , , , , , , , , , , , , , , , , - Haematologica 2020 cited by 169

  24. Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia

    Authors: , , , , , , , , , , , , , , , - JAMA Oncology 2021 cited by 100